RCE recce pharmaceuticals ltd

3.33%

31.0¢

there was nothing retracted and as I indicated they stated...

First 91 Last

Share
Profile

Follow
Grainger

285 Posts.

196

27/02/25

20:06

Post #: 78063099
Share

Originally posted by BelowAverage: ↑

This is actually one of the catalysts for our cynicism. The early results showed that plasma concentrations in the human trials were drastically lower than what was required to kill Sepsis in the earlier animal in vivo studies. A board member on an interview claimed they were high enough but then the company ran another trial where they jacked up the doses even higher. They never released plasma concentration data for this study and from then on Sepsis seemed to fade to the back and was no longer their goal, or talked about. Since then, the trial data released has been lacking to say the least. This has happened several times, if something doesn't work, they hide it, do a pivot in focus and expect us not to realise. Part of the pivot is understandable as they try and hone in on what RCE327 is best suited to. But all the smoke and mirrors, lies and hiding that take place around the pivots makes people like me doubt the trustworthyness of the company and their communications. So when you get a vague dataless 'meets endpoints' result, I worry greatly about how positive it really was.

Expand

there was nothing retracted and as I indicated they stated clearly after the dose finding study that the plasma concentrations were high enough to be effective in sepsis. they also gave the detail of plasma concentrations. are they lying?

RCE Price at posting: 43.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

First 91 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 31.0¢		Change 0.010(3.33%)		Mkt cap ! $89.39M

Open	High	Low	Value	Volume
31.0¢	32.0¢	30.0¢	$25.76K	82.29K

Buyers (Bids)

No.	Vol.	Price($)
2	13550	30.0¢

Sellers (Offers)

Price($)	Vol.	No.
31.0¢	18938	1

View Market Depth

No.	Vol.	Price($)
2	13550	0.300
2	34803	0.295
2	50000	0.290
4	131061	0.285
10	251389	0.280

Price($)	Vol.	No.
0.310	18938	1
0.320	5000	1
0.325	12600	1
0.330	114230	1
0.350	51319	4

Last trade - 16.10pm 27/06/2025 (20 minute delay)

RCE (ASX) Chart

there was nothing retracted and as I indicated they stated...

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

there was nothing retracted and as I indicated they stated...

Top Stories

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News